Combination therapy with losartan and alprostadil for early diabetic nephropathy
Hui Shi
Abstract
Hui Shi
Abstract
Objective:To investigate the curative effects of losartan and alprostadil in the early stage of diabetic nephropathy.Methods:60 patients with the early stage of diabetic nephropathy were divided into 2 groups:combined treatment group and losartan group with 30 cases in each group.The patients were treated with alprostadil and losartan or losartan.Then the levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine were detected before and after the treatment.Results:The levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine of the patients were obviously decreased in 2 groups(P0.05).The data of combined treatment group were better than those of the losartan group(P0.05).Conclusion:The combined treatment of alprostadil and losartan is effect in the early stage of diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the curative effects of losartan and alprostadil in the early stage of diabetic nephropathy.Methods:60 patients with the early stage of diabetic nephropathy were divided into 2 groups:combined treatment group and losartan group with 30 cases in each group.The patients were treated with alprostadil and losartan or losartan.Then the levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine were detected before and after the treatment.Results:The levels of blood pressure,urinary albumin excretion rate,blood urea nitrogen,and serum creatinine of the patients were obviously decreased in 2 groups(P0.05).The data of combined treatment group were better than those of the losartan group(P0.05).Conclusion:The combined treatment of alprostadil and losartan is effect in the early stage of diabetic nephropathy.
Key concepts: Losartan, Medicine, Diabetic nephropathy, Creatinine, Urology, Blood urea nitrogen, Blood pressure, Excretion